The earnings call reflects a positive outlook with strong revenue growth and successful market penetration in the U.S. and Europe. However, challenges in the Chinese market and increased operating expenses present some concerns.

Company Guidance -

Q3 2025

During Establishment Labs' Second Quarter 2025 Earnings Call, the company reported a revenue of $51.3 million, which reflects a 16% growth over the previous year. The U.S. operations contributed $10.3 million, surpassing the anticipated range of $9.5 million to $10 million. This robust performance has led Establishment Labs to raise its full-year revenue guidance to between $208 million and $212 million, indicating a growth projection of 25% to 28%. In terms of profitability, the company improved its adjusted EBITDA loss to $8.5 million from $12.1 million in the first quarter, while cash usage reduced to $14.5 million from $21.2 million. Establishment Labs continues to bolster its market position, particularly in the U.S., where it has reached over 1,000 accounts, and is experiencing notable sales growth in its European direct markets, which saw an increase of approximately 27%. Despite challenges in China, the company remains optimistic about achieving a leadership position there. Establishment Labs aims to achieve its first positive EBITDA quarter later in the year and anticipates being cash flow breakeven by 2026.

Revenue Growth and Guidance Increase

Revenue in the second quarter totaled $51.3 million, a growth of 16% over last year. The company raised its revenue guidance to $208 million to $212 million, representing a growth of 25% to 28%.

Improvement in Operating Profitability

Adjusted EBITDA loss for the quarter was $8.5 million, an improvement from the $12.1 million in the first quarter. Cash use fell to $14.5 million from $21.2 million last quarter.

U.S. Market Success

U.S. sales in the second quarter were $10.3 million, exceeding expectations. The company reached 1,000 accounts in the U.S. and expects U.S. revenue to exceed $40 million.

European Market Growth

European direct market sales increased by approximately 27% this quarter, reflecting a new sales record.

Introduction of Preservé

Preservé, an advanced breast enhancement technique, received positive reception from U.S. surgeons, and the company expects it to command a premium.

Awards and Recognition

The Motiva Flora SmoothSilk Tissue Expander won both the Innovation and Safety Awards in the 2025 Medical Device Network Excellence Awards.

Establishment Labs Holdings (ESTA) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

ESTA Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 11, 2025	2025 (Q3)	-0.51 / -	-0.59	―	―	―
Aug 07, 2025	2025 (Q2)	-0.53 / -0.57	-0.62	8.06% (+0.05)	―
May 07, 2025	2025 (Q1)	-0.81 / -0.70	-0.58	-20.69% (-0.12)	―
Feb 26, 2025	2024 (Q4)	-0.64 / -1.19	-0.79	-50.63% (-0.40)	―
Nov 07, 2024	2024 (Q3)	-0.61 / -0.59	-1.12	47.32% (+0.53)	―
Aug 06, 2024	2024 (Q2)	-0.51 / -0.62	-0.65	4.62% (+0.03)	―
May 08, 2024	2024 (Q1)	-0.67 / -0.58	-0.48	-20.83% (-0.10)	―
Feb 28, 2024	2023 (Q4)	-0.91 / -0.79	-0.55	-43.64% (-0.24)	―
Nov 07, 2023	2023 (Q3)	-0.80 / -1.12	-0.76	-47.37% (-0.36)	―
Aug 08, 2023	2023 (Q2)	-0.72 / -0.65	-1.52	57.24% (+0.87)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

ESTA Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 07, 2025	$41.79	$35.96	-13.95%
May 07, 2025	$33.27	$34.80	+4.60%
Feb 26, 2025	$36.06	$42.53	+17.94%
Nov 07, 2024	$48.12	$46.25	-3.89%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Establishment Labs Holdings Inc (ESTA) report earnings?

Establishment Labs Holdings Inc (ESTA) is schdueled to report earning on Nov 11, 2025, Before Open (Confirmed).

What is Establishment Labs Holdings Inc (ESTA) earnings time?

Establishment Labs Holdings Inc (ESTA) earnings time is at Nov 11, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is ESTA EPS forecast?

ESTA EPS forecast for the fiscal quarter 2025 (Q3) is -0.51.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing